Cargando…
Human corneal stromal stem cells express anti-fibrotic microRNA-29a and 381-5p – A robust cell selection tool for stem cell therapy of corneal scarring
INTRODUCTION: Corneal blindness due to scarring is treated with corneal transplantation. However, a global problem is the donor material shortage. Preclinical and clinical studies have shown that cell-based therapy using corneal stromal stem cells (CSSCs) suppresses corneal scarring, potentially med...
Autores principales: | Yam, Gary Hin-Fai, Yang, Tianbing, Geary, Moira L, Santra, Mithun, Funderburgh, Martha, Rubin, Elizabeth, Du, Yiqin, Sahel, Jose A, Jhanji, Vishal, Funderburgh, James L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006527/ https://www.ncbi.nlm.nih.gov/pubmed/35623612 http://dx.doi.org/10.1016/j.jare.2022.05.008 |
Ejemplares similares
-
The anti-scarring effect of corneal stromal stem cell therapy is mediated by transforming growth factor β3
por: Weng, Lin, et al.
Publicado: (2020) -
Combined Therapy Using Human Corneal Stromal Stem Cells and Quiescent Keratocytes to Prevent Corneal Scarring after Injury
por: Jhanji, Vishal, et al.
Publicado: (2022) -
Compressed Collagen Enhances Stem Cell Therapy for Corneal Scarring
por: Shojaati, Golnar, et al.
Publicado: (2018) -
Corneal stromal stem cells reduce corneal scarring by mediating neutrophil infiltration after wounding
por: Hertsenberg, Andrew J., et al.
Publicado: (2017) -
Molecular and Cellular Mechanisms of Corneal Scarring and Advances in Therapy
por: Fuest, Matthias, et al.
Publicado: (2023)